Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Insulet Corporation - Common Stock
(NQ:
PODD
)
288.36
-0.46 (-0.16%)
Streaming Delayed Price
Updated: 11:25 AM EST, Dec 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Insulet Corporation - Common Stock
< Previous
1
2
3
4
5
Next >
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
December 15, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
December 04, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
November 20, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Reports Third Quarter 2025 Results
November 06, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
October 30, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
October 23, 2025
From
Insulet Corporation
Via
Business Wire
Insulet to Host Investor Day on November 20, 2025
October 10, 2025
From
Insulet Corporation
Via
Business Wire
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
September 18, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Announces CFO Transition
September 16, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Elevates Eric Benjamin to Chief Operating Officer
August 25, 2025
From
Insulet Corporation
Via
Business Wire
Insulet to Participate in Upcoming Investor Conferences
August 19, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)
August 07, 2025
From
Insulet Corporation
Via
Business Wire
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
July 08, 2025
From
Insulet Corporation
Via
Business Wire
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
June 19, 2025
From
Insulet Corporation
Via
Business Wire
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
June 17, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END
Via
FinancialNewsMedia
Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
June 10, 2025
From
Insulet Corporation
Via
Business Wire
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
June 17, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
May 23, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Announces Publication of 2024 Sustainability Report
May 13, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)
May 08, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Appoints Ashley McEvoy President and CEO
April 28, 2025
From
Insulet Corporation
Via
Business Wire
Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025
April 03, 2025
From
Insulet Corporation
Via
Business Wire
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections
March 19, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Announces Pricing of Senior Notes Due 2033
March 18, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Announces Proposed Financing Transactions
March 18, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Expands Omnipod® 5 to Four More International Markets
March 18, 2025
From
Insulet Corporation
Via
Business Wire
From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes
March 18, 2025
From
Insulet Corporation
Via
Business Wire
Insulet to Host Investor Day on June 5, 2025
March 11, 2025
From
Insulet Corporation
Via
Business Wire
Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year
February 20, 2025
From
Insulet Corporation
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
